MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
J15 · Effective Aug 6, 2023
13 active Medicare policies list D22.20, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Aug 6, 2023
JE · Effective Aug 6, 2023
JF · Effective Aug 6, 2023
JJ · Effective Aug 6, 2023
JM · Effective Aug 6, 2023
J5 · Effective Aug 13, 2023
J8 · Effective Aug 13, 2023
J9 · Effective Oct 1, 2015
National · Effective Aug 6, 2023
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D22.20 |
|---|---|---|
| Intraoperative Neurophysiological Monitoring | Oct 26, 2023 | Covered |
National · Effective Jan 22, 2026
National · Effective Jan 22, 2026
J5 · Effective Sep 25, 2025
National · Effective Oct 30, 2025